Customization: | Available |
---|---|
Function: | Hormones and Regulation of Endocrine Function of Drug |
Certification: | GMP |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Cinacalcet Hydrochloride
Generic Name: Cinacalcet Hydrochloride
CAS: C22H23CIF3N
Indication: This products is suitable for the treatment of chronic kidney disease (CKD) maintenance dialysis patients secondary hyperparathyroidism.
SSY Group Limited, established in 1948, principally specializes in R&D, manufacture, and sale of a widerange of pharmaceutical products, including various dosage forms such as intravenous injections, tablets, capsule, ampoules, APIs and medical packaging materials.The main subsidiaries of SSY are as follows
Shijiazhuang No 4 Pharmaceutical Co, Ltd
Hebei Guangxiang Pharmaceutical Co, Ltd.
Hebei Guolong Pharmaceutical Co, Ltd
Jiangsu Best New Medical Material Co, Ltd.
Hebei Hanlin Bio-tech Co., Ltd.
With more than 70-year development, our products
have been sold to both domestic and overseas markets up to more than 80 countries and regions.
Hebei Guangxiang Pharmaceutical Co., Ltd. is a super-large pharmaceutical enterprise, with 3 billion RMB investment and an area of 1000mu(equals to about 667,000m2) in the Biomedical Industrial Park of Cangzhou Bohai New Area. It seizes the timely opportunity of Beijing-Tianjin-Hebei integrated development and firmly relies on the abundant capital, R&D strength and brand influence of SSY Group. Concentrating on API, intermediate compounds and bio-pharmaceutical preparations, its main products are API series products, metronidazole, nifedipine, theophylline, aminophylline, azithromycin, abidol and other series of products and biomedical preparations.
The manufacturing of main products among them- API series products replaces traditional intermittent production into intelligent continuous production with advanced process equipment, automation and information technology, greatly improving production efficiency.